Key facts
- This page summarizes Otello Stampacchia's Form 4 filing for ImageneBio, Inc. (IMA).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 18 Jun 2026, 18:45.
Otello Stampacchia - 16 Jun 2026 Form 4 Insider Report for ImageneBio, Inc. (IMA)
- Reporting relationship
- Director
- Issuer ticker
- IMA
- Reported as of
- 16 Jun 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 18 Jun 2026, 18:45:13 UTC
- Prior SEC filing
- 30 Jul 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kristin Yarema, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Otello Stampacchia filed Form 4 for ImageneBio, Inc. (IMA) on 18 Jun 2026.
Change
- Previous filing in this sequence was filed on 30 Jul 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001361712
Primary reporting owner
Stampacchia Otello
- Relationship
- Director
- Address
- C/O IMAGENEBIO, INC., 12526 HIGH BLUFF DRIVE, SUITE 345, SAN DIEGO
- Signature
- /s/ Kristin Yarema, Attorney-in-Fact
- Signature date
- 18 Jun 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IMA
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- Shares
- +15,600
- Change %
- Price
- $0.000000*
- Shares after
- 15,600
- Date
- 16 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 15,600
- Exercise price
- $5.45
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The shares vest in full upon the earlier to occur of the first anniversary of the date of grant, the date of the Issuer's next annual meeting or a change of control as defined in the Issuer's 2025 Equity Incentive Plan.